ArticlePediatric gastroenterology, hepatology & nutrition2026
High Prevalence of Steatotic Liver in Adolescents and Young Adults in a Northern California Community.
Article in Pediatric gastroenterology, hepatology & nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The prevalence of steatotic liver disease (SLD) in adolescents and young adults (AYA) is poorly understood. While the recognition of the importance of this condition as a precursor to serious liver disease is growing, the impact on young people is not well documented. The majority of SLD data is derived from older subjects undergoing a clinically indicated procedure. This study seeks to better describe the prevalence and associated factors for SLD in AYA. Methods: A convenience sample of 241 patients aged 14-30 in Northern California was recruited. Demographic, dietary, exercise and biometric data were collected. Logistic regression models were applied to assess the association between collected data and body mass index (BMI) categories with SLD presence. A diagnostic cut-off of controlled attenuation parameter ≥238 dB/m on transient elastography was used to define SLD. Results: The prevalence of SLD was 59/241 (24.8%). BMI was a predictor of SLD, with 0.0% (0/12) of underweight, 8.5% (11/129) of normal, 28.1% (18/64) of overweight and 83.3% (30/36) of obese participants having hepatic steatosis in this sample. Conclusion: The prevalence of SLD was unexpectedly high, particularly among subjects who were overweight or obese. The increasing diagnosis of SLD in young populations requires a better understanding of factors that may predict or protect from developing fatty liver. Similar to previous reports, BMI was the main predictor of SLD in our population. This study highlights a possible concerning finding of SLD starting at a young age and for consideration of standardized guidelines for screening in AYA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.